FMC63

FMC63バックグランド

FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

レビュー

  • H***e2026-03-28
    1評価
    My team has been using the Anti-FMC63 Antibody, and they always have consistent and reliable data that is being used for preclinical IND-enabling studies as well as clinical studies. I recommend using AcroBiosystems for your antibody needs.
  • X***g2026-03-28
    1評価
    Our bioanalytical team have consistently obtained reliable CAR detection results using the PE‑labeled monoclonal anti‑FMC63 antibody in our animal studies. The antibody shows strong specificity, clear signal, and low background, with consistent performance across runs. Overall, it has been a dependable, high‑quality reagent, and we consider the vendor a reliable supplier for CAR detection assays.
  • G***o2025-11-06
    1評価
    The FM3-PY54A2 PE antibody from AcroBiosystems has proven to be an outstanding reagent for flow cytometry applications. It delivers exceptional signal clarity and consistency, providing optimal staining and reproducible results across multiple experimental runs. The antibody exhibits high specificity and minimal background, ensuring precise detection and reliable data quality. Overall, this product demonstrates excellent performance and stability, making it a highly recommended choice for researchers seeking robust and accurate flow cytometry analysis.
詳しく読む
  • 製品リスト
  • レビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8